← Oncology Approval Tracker

FDA DECISION ·

Opdivo + cisplatin + gemcitabine

nivolumab with cisplatin and gemcitabine · Bristol Myers Squibb

FDA approvalNew or expanded indicationUrothelial carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First-line treatment for adults with unresectable or metastatic urothelial carcinoma with nivolumab, cisplatin and gemcitabine.

LAMPGEN ANALYSIS

Why it matters

The decision established a checkpoint inhibitor and cisplatin-based chemotherapy combination in untreated advanced urothelial disease.

What research teams should watch

Document baseline cisplatin fitness and track where chemotherapy ends and nivolumab maintenance begins.

PRIMARY RECORDS

Sources